Bicara Therapeutics Inc.(BCAX) - 2025 Q4 - Earnings Call Transcript

Bicara Therapeutics (NasdaqGM:BCAX) Q4 2025 Earnings call March 30, 2026 08:30 AM ET Company ParticipantsClaire Mazumdar - CEOEva Fortea - VP, Equity ResearchIvan Hyep - CFOLana Usmanova - Research AssociateRachel Frank - Senior Director and Head of Investor Relations and Corporate CommunicationsRyan Cohlhepp - President and COOStephen Willey - Managing DirectorTanya Green - Chief Development OfficerConference Call ParticipantsEric Schmidt - AnalystJeet Mukherjee - Biotechnology AnalystJudah Frommer - Equit ...